Tonix Pharmaceuticals
TNXP
#10222
Rank
S$70.66 M
Marketcap
S$3.64
Share price
-4.08%
Change (1 day)
-82.86%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -S$0.21 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are S$29.1 Million. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$96.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.21 Billion33.7%
2025 -S$0.16 Billion61.37%
2024 -S$96.95 Million-36.5%
2023 -S$0.16 Billion5.61%
2022 -S$0.15 Billion21.43%
2021 -S$0.12 Billion82.76%
2020 -S$65.14 Million75.22%
2019 -S$37.18 Million9.52%
2018 -S$33.95 Million23.63%
2017 -S$27.46 Million-45.36%
2016 -S$50.26 Million-19.09%
2015 -S$62.11 Million74.15%
2014 -S$35.67 Million153.99%
2013 -S$14.05 Million
2011 -S$6.78 Million29538.74%
2010 -S$0.03 Million-42.58%
2009 -S$0.04 Million46.05%
2008 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-S$29.97 Million-85.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
S$45.98 M-121.96%๐Ÿ‡บ๐Ÿ‡ธ USA